Factors that Influence Health-Related Quality of Life in Patients with Primary Sclerosing Cholangitis
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Background Primary sclerosing cholangitis (PSC) is an incurable, cholestatic liver disease often coincident with inflammatory bowel disease (IBD).Aims To evaluate the impact of liver disease and IBD on health-related quality of life (HRQoL) in PSC.Methods A mixed-methods, cross-sectional study was performed at a tertiary center. Short Form-36 (SF-36) scores were compared between PSC, Canadian normative data, and disease controls. Disease-specific instruments scores [PBC-40, Short IBD questionnaire, Liver Disease Quality of Life Questionnaire (LDQOL)] were compared between PSC and disease controls. Multivariable regression identified factors independently associated with final SF-36 component scores. Qualitative evaluation of patient questionnaires was performed using a content analysis framework.Results One hundred and sixty-two surveys were completed (99 PSC, 26 primary biliary cirrhosis, 16 non-autoimmune cholestatic liver disease, and 21 IBD). PSC patients had significantly lower SF-36 scores than Canadian controls, but similar scores to disease controls. LDQOL most accurately predicted HRQoL. Factors negatively associated with physical HRQoL included shorter IBD duration, liver disease symptoms, and decompensated cirrhosis. Mental HRQoL was influenced by liver disease and IBD symptoms, pruritus, social isolation, and depression. Nearly 75 % expressed existential anxiety regarding disease progression and diminished life expectancy, with 25 % disclosing social isolation.Conclusions Patients with PSC have significantly lower HRQoL than healthy controls. Both symptoms of IBD and chronic liver disease impact HRQoL in patients with PSC, which lead to significant psychologic burden that is expressed by existential anxieties and social isolation. A PSC-specific HRQoL tool is critical to adequately quantify the distinct impact of IBD and cholestatic liver disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“People with PSC have a decreased quality of life and dealing with uncertainties about course of disease and risk of cancer can generate anxiety, depression and social isolation.456,464”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [456]
In the citing paper
“The mental component scores appear to be influenced by lifestyle modifications secondary to liver disease, social interactions and loneliness, and were worse in patients with more severe itching, shorter IBD duration and depression.456”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [456]
In the citing paper
“People with PSC have a decreased quality of life and dealing with uncertainties about course of disease and risk of cancer can generate anxiety, depression and social isolation.456,464”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [456]
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Analysis of Incomplete Multivariate Data
Schafer, J. L. (1997) · doi:10.1201/9781439821862 · Cited by 6,012
Analysis of Incomplete Multivariate Data
Booth, D. E. (2000) · Technometrics · doi:10.1080/00401706.2000.10486013 · Cited by 5,627
(2011) · Encyclopedia of Cancer · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,240
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R., Fevery, J., Kalloo, A., Nagorney, D. M., Boberg, K. M., Shneider, B., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,224
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
Hopman, W. M., Towheed, T., Anastassiades, T., Tenenhouse, A., Poliquin, S., Berger, C., Joseph, L., Brown, J. P., Murray, T. M., Adachi, J. D., et al. (2000) · Europe PMC (PubMed Central) · Cited by 867
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
Broomé, U., Olsson, R., Lööf, L., Bodemar, G., Hultcrantz, R., Danielsson, A., Prytz, H., Sandberg-Gertzén, H., Wallerstedt, S., & Lindberg, G. (1996) · Gut · doi:10.1136/gut.38.4.610 · Cited by 819
Irvine, E. J., Zhou, Q., & Thompson, A. K. (1996) · PubMed · Cited by 667
Celaya, F. B. (1989) · Anales de Medicina Interna · Cited by 508
Natural history and prognostic variables in primary sclerosing cholangitis
Farrant, J. M., Hayllar, K. M., Wilkinson, M. L., Karani, J., Portmann, B. C., Westaby, D., & Williams, R. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90673-9 · Cited by 468
Canadian normative data for the SF-36 health survey
Hopman, W. M., Towheed, T., Anastassiades, T., Tenenhouse, A., Poliquin, S., Berger, C., Joseph, L., Brown, J. P., Murray, T. M., Adachi, J. D., et al. (2000) · Europe PMC (PubMed Central) · Cited by 310
Ponsioen, C. Y., Vrouenraets, S. M. E., Prawirodirdjo, W., Rajaram, R., Rauws, E. A. J., Mulder, C. J. J., Reitsma, J. B., Heisterkamp, S. H., & Tytgat, G. N. J. (2002) · Gut · doi:10.1136/gut.51.4.562 · Cited by 268
Jacoby, A., Rannard, A., Buck, D., Bhala, N., Newton, J. L., James, O. F. W., & Jones, D. E. J. (2005) · Gut · doi:10.1136/gut.2005.065862 · Cited by 267
Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease
Boonstra, K., van Erpecum, K. J., van Nieuwkerk, K. M. J., Drenth, J. P. H., Poen, A. C., Witteman, B. J. M., Tuynman, H. A. R. E., Beuers, U., & Ponsioen, C. Y. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22938 · Cited by 262
Feakins, R. M. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2013-201885 · Cited by 237
Jowett, S. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)03244-0 · Cited by 208
Gralnek, I. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02168-7 · Cited by 199
Cholestatic liver diseases and health-related quality of life
Younossi, Z. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00833-3 · Cited by 166
The coefficient of determination and its adjusted version in linear regression models
Srivastava, A. K., Srivastava, V. K., & Ullah, A. (1995) · Econometric Reviews · doi:10.1080/07474939508800317 · Cited by 88
Kanwal, F., Hays, R. D., Kilbourne, A. M., Dulai, G. S., & Gralnek, I. M. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30300.x · Cited by 84
Factors That Reduce Health-Related Quality of Life in Patients With Primary Sclerosing Cholangitis
Valle, M., Rahman, M., Lindkvist, B., Bjornsson, E. S., Chapman, R. W., & Kalaitzakis, E. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.01.025 · Cited by 69
Primary Sclerosing Cholangitis
Williamson, K. D., & Chapman, R. W. (2014) · Digestive Diseases · doi:10.1159/000358150 · Cited by 51
Raszeja‐Wyszomirska, J., Wunsch, E., Krawczyk, M., Rigopoulou, E. I., Bogdanos, D., & Milkiewicz, P. (2015) · Liver International · doi:10.1111/liv.12730 · Cited by 43 · cited 14×
“Interestingly, cirrhosis has been shown to be a strong determinant of physical, but not mental, HRQoL as measured by the SF-36 [21, 23], which is supported by the results of our study.”
ResultInfluentialHealth‐related quality of life among patients with primary sclerosing cholangitis
Haapamäki, J., Tenca, A., Sintonen, H., Barner‐Rasmussen, N., & Färkkilä, M. A. (2015) · Liver International · doi:10.1111/liv.12775 · Cited by 42
Theede, K., Kiszka‐Kanowitz, M., Nordgaard-Lassen, I., & Nielsen, A. M. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv081 · Cited by 36
Ananthakrishnan, A. N., Beaulieu, D. B., Ulitsky, A., Zadvornova, Y., Skaros, S., Johnson, K., Naik, A., Perera, L., Issa, M., Binion, D. G., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21051 · Cited by 32
Primary sclerosing cholangitis
Chapman, R. W. (2011) · Medicine · doi:10.1016/j.mpmed.2011.07.003 · Cited by 14
Cited by
Primary sclerosing cholangitis – a comprehensive review
Karlsen, T. H., Folseraas, T., Thorburn, D., & Vesterhus, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.022 · Cited by 868
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Bowlus, C. L., Arrivé, L., Bergquist, A., Deneau, M., Forman, L., Ilyas, S. I., Lunsford, K. E., Martinez, M., Sapisochin, G., Shroff, R., et al. (2023) · Hepatology · doi:10.1002/hep.32771 · Cited by 428
EASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419
Chapman, M. H., Thorburn, D., Hirschfield, G. M., Webster, G. G. J., Rushbrook, S. M., Alexander, G., Collier, J., Dyson, J. K., Jones, D. E., Patanwala, I., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317993 · Cited by 284
Self-citationThe vicious cycle of itch and anxiety
Sanders, K. M., & Akiyama, T. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.01.009 · Cited by 179
Metadata
- Authors
- Cheung, A. C., Patel, H., Meza-Cardona, J., Cino, M., Sockalingam, S., & Hirschfield, G. M.
- Affiliations
- University of Toronto (CA)
- University Health Network (CA)
- University of Birmingham (GB)
- Corresponding author
- Cheung, Angela C.
- Venue
- Digestive Diseases and Sciences
- Published
- 2016-01-07
- Volume
- 61
- Issue
- 6
- Pages
- 1692-1699
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W2230144481
- Cited by
- 68
- References
- 31
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 2 · 2023: 9 · 2022: 11 · 2021: 7 · 2020: 7 · 2019: 4 · 2018: 6 · 2017: 6 · 2016: 1
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Digestive Diseases and Sciences (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- PSC Partners Seeking a Cure
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- primary sclerosing cholangitis, health-related quality of life, inflammatory bowel disease, cholestatic liver disease, pruritus, social isolation, depression, existential anxiety, decompensated cirrhosis, disease-specific quality of life instruments, psychological burden
- MeSH terms
- Adult, Aged, Data Collection, Female, Humans, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Cholangitis, Sclerosing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.